Form 4: Delek US Holdings EVP Sells Shares Under 10b5-1 Plan
Insider Trading Report
Delek US Holdings' EVP of Special Projects, Reuven Spiegel, sold 27,000 shares of common stock in two transactions under a pre-arranged 10b5-1 trading plan.
Summary
- Reuven Spiegel, Executive Vice President of Special Projects at Delek US Holdings, Inc. (DK), reported the sale of 27,000 shares of the company's common stock.
- The transactions occurred on November 11, 2025.
- The first sale involved 17,000 shares at a weighted average price of $41.42 per share, with individual sale prices ranging from $41.39 to $41.59.
- The second sale involved 10,000 shares at a weighted average price of $41.25 per share, with individual sale prices ranging from $41.16 to $41.37.
- Following these sales, Reuven Spiegel's direct beneficial ownership of Delek US Holdings common stock stands at 23,020 shares.
- Both sales were executed pursuant to a Rule 10b5-1 trading plan, which was initially adopted on March 6, 2025, and subsequently amended on August 13, 2025.
Sentiment
Score: 4
Explanation: An executive's sale of a significant number of shares, even under a pre-arranged 10b5-1 plan, can be perceived as a mild negative signal regarding management's long-term conviction in the stock, though the pre-planned nature reduces the immediate bearish implication.
Negatives
- An executive selling a significant number of shares (27,000 shares) could be perceived negatively by the market, even if pre-planned.
- The total value of shares sold across both transactions is approximately $1,117,000.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: May interpret the insider sale as a slight negative signal, potentially impacting investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 2025-03-06 | Adoption date of the Rule 10b5-1 trading plan. |
| 2025-08-13 | Amendment date of the Rule 10b5-1 trading plan. |
| 2025-11-11 | Date of common stock sales by Reuven Spiegel. |
| 2025-11-13 | Filing date of the Form 4. |
Recommendation
holdWhile an insider sale, even under a 10b5-1 plan, can be a mild negative signal, it is not strong enough on its own to warrant a 'sell' recommendation. The pre-planned nature suggests it is for personal financial planning rather than a reaction to new negative company-specific information. Without additional context on company performance or industry trends, a 'hold' recommendation is appropriate, advising investors to monitor future developments.
Keywords
Delek US Holdings, DK, Reuven Spiegel, Insider Sale, Form 4, 10b5-1 Plan, Executive Stock Sale, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.